---
document_datetime: 2025-07-11 14:08:06
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/binocrit-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: binocrit-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 3.2698814
conversion_datetime: 2025-12-17 14:31:18.585783
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Binocrit

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthecompleteproductlifecycleprocedures,youmayneedtoalsorefertoEPAR-Proceduralstepstakenandscientific informationafterauthorisation(archive).

| Applicationnumber   | Scope                              | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ² / amendedon   | Product Information affected3   | Summary   |
|---------------------|------------------------------------|-------------------------------------|-------------------------------------------|---------------------------------|-----------|
| VariationtypeIA_IN/ | B.Il.b.2.cReplacementoradditionofa | 11/07/2025                          |                                           | Annex II and                    |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions areissuedforallotherprocedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex Il, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (Eu) No. 712/2012, or within one year for other procedures.

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000278097                     | manufacturer responsiblefor importation and/or batch release - B.II.b.2.c.1 Not includingbatch control/testing-Accepted                                                                                                |            |     | PL   |
|---------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|
| Variation type IA / EMA/VR/0000265273 | B.III.2 Change to complywithPh.Eur.or withanationalpharmacopoeiaofaMember State - B.III.2.b Change to comply with an update of the relevant monograph of the Ph. Eur.ornationalpharmacopoeiaofaMember State - Accepted | 16/04/2025 | N/A |      |